Usefulness of highly active antiretroviral therapy on health-related quality of life of adult recipients in Tanzania

AIDS Patient Care and STDs

Volumn 23, Issue 7, 2009, Pages 563-570

  Magafu, Mgaywa G M D ^a   Moji, Kazuhiko ^b   Igumbor, Ehimario U ^c   Hashizume, Masahiro ^a   Mizota, Tsutomu ^a   Komazawa, Osuke ^a   Cai, Guoxi ^b   Yamamoto, Taro ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR HUMANITY AND NATURE   (Japan)

^c UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL HEALTH; PATIENT COMPLIANCE; POPULATION; QUALITY OF LIFE; SHORT FORM 36; TANZANIA; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HIV INFECTIONS; HIV-1; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TANZANIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69249144843     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0278     Document Type: Article

References (33)

1. Ministry of Health, Tanzania. National guidelines for the clinical management of HIV and AIDS. Dar-es-Salaam, Tanzania: National AIDS Control Program; 2005.
2. Kagera Regional Hospital. Annual report. Bukoba, Tanzania: Kagera Regional Hospital, 2006.
3. Office of the Municipal Director of Bukoba. Bukoba Urban District. Bukoba, Tanzania: Bukoba Municipal Office, 2005.
4. Ministry of Health, Kenya. National training curriculum on anti-retroviral therapy. Nairobi, Kenya: National AIDS and STDs Control Program, 2005.
5. Wu AW. Quality of life assessment comes of age in the era of highly active anti-retroviral therapy. AIDS 2000;14:1449-1451.
6. O'Boyle CA, Waldron D. Quality of life issues in palliative medicine. J Neurol 1997;244(4):S18-25. (Pubitemid 27485011)
7. Badia X, Baro E. The measurement of health-related quality of life in prospective drug therapy studies in HIV-infected patients. AIDS Rev 1999;1:213-220.
8. Hays RD, Cunningham WE, Sherbourne C, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV cost and services utilization study. Am J Med 2000;108:714-722. (Pubitemid 30621459)
9. Campsmith ML, Nakashima KA, Davidson AJ. Self-reported health-related quality of life in persons with HIV infection: Results from a multi-site interview project. Health Qual Life Outcomes 2003;1:12.
10. Haonga M. Concern over HIV resistance. The Guardian, Tanzania. October 23, 2008:1.
11. Wyss K, Wagner AK, Whitining D, et al. Validation of the Kiswahili version of the SF-36 Health Survey in a representative sample of an urban population in Tanzania. Qual Life Res 1999;8:111-120. (Pubitemid 29362752)
12. Shacham E, Reece M, Ong'or WO, et al. Characteristics of psychosocial support seeking during HIV-related treatment in western Kenya. AIDS Patient Care STDs 2008; 22:595-601.
13. Myer L, Smit J, Roux LL, et al. Common mental disorders among HIV-infected individuals in South Africa: Prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs 2008;22:147-158. (Pubitemid 351252588)
14. UNAIDS. Report on the global AIDS epidemic: Executive summary. Geneva, Switzerland: UNAIDS, 2006.
15. Kagera AIDS Research Project (KARP). www.muchs.ac.tz/kageraproject/index. html (Last accessed December 18, 2006).
16. Kwesigabo G. Trends of HIV infection in the Kagera region of Tanzania [PhD thesis]. Umea, Sweden: Umea University, 2001.
17. Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), ORC Macro. Tanzania HIV/AIDS indicator survey 2003-2004 Calverton, MD: TACAIDS, NBS and ORC Macro, 2005.
18. Tanzania Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), MEASURE DHS. Tanzania HIV/AIDS and malaria indicator survey 2007-2008: Preliminary report. Calverton, MD: TACAIDS, NBS and MEASURE DHS, 2008.
19. Wagner AK, Wyss K, Gandek B, Kilima PM, Lorenz S, Whitining D. A Kiswahili version of the SF-36 Health Survey for use in Tanzania: Translation and tests of scaling assumptions. Qual Life Res 1999;8:101-110. (Pubitemid 29362751)
20. Nemeth, G. Health-related quality of life outcome instruments. Eur Spine J 2006;15:S44-51. (Pubitemid 43188548)
21. Hardon A, Davey S, Gerrits T, et al. From access to adherence: The challenges of anti-retroviral treatment: Studies from Botswana, Tanzania and Uganda. Geneva, Switzerland: WHO, 2006.
22. Ware JE Jr, Kosinski M, Gandek, B. SF-36 Health Survey: Manual and interpretation guide. Lincoln, USA: Quality-Metric Incorporated; 2000.
23. Liu C, Ostrow D, Detels D, et al. Impacts of HIV infection and HAART use on quality of life. Qual Life Res 2006; 15:941-949. (Pubitemid 44221448)
24. Miners AH, Sabin CA, Mocroft A, Youle M, Fisher M, Johnson M. Health-related quality of life in individuals infected with HIV in the era of HAART. HIV Clin Trials 2001; 2:484-492. (Pubitemid 33138714)
25. Arpinelli F, Visona G, Bruno R, De Carli G, Apolone G. Health-related quality of life in asymptomatic patients with HIV: Evaluation of the SF-36 Health Survey in Italian patients. Pharmacoeconomics 2000;18:63-72. (Pubitemid 30468869)
26. U.S. Census Bureau. International Database (IDB). www.census.gov/ipc/www/ idb/pyramids.html (Last accessed January 27, 2009).
27. Low-Beer S, Chan K, Wood E, et al. Health-related quality of life among persons with HIV after the use of protease inhibitors. Qual Life Res 2000;9:941-949. (Pubitemid 32210188)
28. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res 1997;6:531-554. (Pubitemid 27431708)
29. Burgoyne RW, Rourke SB, Behrens DM, Salit IE. Long-term quality of life outcomes among adults living with HIV in the HAART era: The interplay of changes in clinical factors and symptom profile. AIDS Behav 2004;8:151-163.
30. Eriksson LE, Bratt GA, Sandstrom E, Nordstrom G. The two-year impact of first generation protease inhibitor-based antiretroviral therapy (PI-ART) on health-related quality of life. Health Qual Life Outcomes 2005;4;3:32. (Pubitemid 41522156)
31. Kohli RM, Sane S, Kumar K, Paranjape RS, Mehendale SM. Assessment of quality of life among HIV-infected persons in Pune, India. Qual Life Res 2005;14:1641-1647. (Pubitemid 40848244)
32. Call SA, Klapow JC, Stewart KE, et al. Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res 2000;9:977-985. (Pubitemid 32289935)
33. Shumaker SA, Ellis S, Naughton M. Assessing health-related quality of life in HIV disease: Key measurement issues. Qual Life Res 1997;6:475-480. (Pubitemid 27431703)